VEGFA and neoplasm: Tumor-associated macrophages have been reported to confer resistance to 5-fluorouracil [37], and Treg-low TMEs appear more responsive to immune checkpoint blockade [38], and macrophage-rich TMEs might facilitate vessel co-option, which is linked to liver-dominant spread and resistance to anti-VEGF therapy [39].